The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy

The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy

Show other versions (1)

Renin-angiotensin-aldosterone system inhibitors prevent the progression of kidney disease in patients with diabetic nephropathy, and we studied how that benefit varies by the type of diabetes and baseline urinary albumin. We pooled data from 49 randomized controlled trials in a meta-analysis using t...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Taylor, K, Stevens, R, Blacklock, C, Roberts, N, Pugh, C, Farmer, A, Hirst, J
Format:	Journal article
Sprog:	English
Udgivet:	2012

Lignende værker

The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy.
af: Hirst, J, et al.
Udgivet: (2012)

Evidence for a dose effect of renin-angiotensin system inhibition on progression of microalbuminuria in Type 2 diabetes: a meta-analysis.
af: Blacklock, C, et al.
Udgivet: (2011)

Advances in the Renin-Angiotensin-Aldosterone System: Relevance to Diabetic Nephropathy
af: Audrey Koitka, et al.
Udgivet: (2008-01-01)

Renin Angiotensin Aldosterone System Gene Polymorphisms among Type 2 Diabetic Patients with Retinopathy and Nephropathy
af: Vaishali S. Pawar, et al.
Udgivet: (2024-12-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes: the role of renin-angiotensin-aldosterone system (literature review) (part 2)
af: K. V. Skobeleva, et al.
Udgivet: (2021-06-01)

Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
af: Yan-Huan Feng, et al.
Udgivet: (2016-01-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes mellitus: the role of renin-angiotensin-aldosterone system (literature review) (part 1)
af: K. V. Skobeleva, et al.
Udgivet: (2021-06-01)

Renin‐Angiotensin‐Aldosterone System, Glucose Metabolism and Incident Type 2 Diabetes Mellitus: MESA
af: Joshua J. Joseph, et al.
Udgivet: (2018-09-01)

Network pharmacology combined with Mendelian randomization analysis to identify the key targets of renin-angiotensin-aldosterone system inhibitors in the treatment of diabetic nephropathy
af: Dongqi Zhou, et al.
Udgivet: (2024-01-01)

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Overview of Regulation of the Renin–Angiotensin–Aldosterone System
af: Akira Nishiyama, et al.
Udgivet: (2010-01-01)

The efficacy and safety of dual blockage of the renin-angiotensin-aldosterone system in patients with type 2 diabetes, hypertension and obesity without renal dysfunction
Udgivet: (2012-09-01)

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
af: Andre Feldman, et al.
Udgivet: (2020-11-01)

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
af: Andre Feldman, et al.
Udgivet: (2020-11-01)

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
af: Andre Feldman, et al.
Udgivet: (2020-11-01)

Renin-angiotensin-aldosterone system inhibitors and the COVID-19 epidemic
af: José Silva-Cardoso, et al.
Udgivet: (2022-10-01)

How to potentialize the effect of renin-angiotensin-aldosterone system inhibitors?
af: D.D. Ivanov
Udgivet: (2021-09-01)

Use of maximal dosage renin-angiotensin-aldosterone system inhibitors in a real life population of complicated type 2 diabetes – contraindications and opportunities
af: C. M. Gant, et al.
Udgivet: (2023-08-01)

Analysis of renin-angiotensin aldosterone system gene polymorphisms in Malaysian essential hypertensive and type 2 diabetic subjects
af: Ramachandran, Vasudevan, et al.
Udgivet: (2009)

Analysis of renin-angiotensin aldosterone system gene polymorphisms in malaysian essential hypertensive and type 2 diabetic subjects
af: Stanslas Johnson, et al.
Udgivet: (2009-02-01)

Association of renin-angiotensin system genes polymorphism with progression of diabetic nephropathy in patients with type 1 diabetes mellitus
af: Ilić Vesna, et al.
Udgivet: (2014-01-01)

Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin–Angiotensin–Aldosterone System Blockers
af: Yuichiro Ueda, et al.
Udgivet: (2016-01-01)

Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin–Angiotensin–Aldosterone System Blockers
af: Yuichiro Ueda, et al.
Udgivet: (2016-09-01)

Novel Class of Central Renin Angiotensin Aldosterone System Inhibitor: Firibastat
Udgivet: (2022-05-01)

Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review
af: Filipe Ferrari, et al.
Udgivet: (2021-04-01)

Renin‐Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID‐19
af: Jordan Loader, et al.
Udgivet: (2021-08-01)

Genetic polymorphism of renin-angiotensin-aldosterone system in type 2 diabetes and in combination with arterial hypertension among Dagestan inhabitants
af: Marat Z. Saidov, et al.
Udgivet: (2019-12-01)

The renin angiotensin aldosterone system and COVID-19
af: Hadeel A. Alsufyani, et al.
Udgivet: (2020-08-01)

Beyond the circulating renin angiotensin aldosterone system
af: Walmor eDe Mello
Udgivet: (2014-07-01)

Influence of renin‐angiotensin‐aldosterone system inhibitors on plasma levels of angiotensin‐converting enzyme 2
af: Tobias Zimmermann, et al.
Udgivet: (2021-04-01)

Dynamic Changes in the Renin-Angiotensin-Aldosterone System and the Beneficial Effects of Renin-Angiotensin-Aldosterone Inhibitors on Spatial Learning and Memory in a Rat Model of Chronic Cerebral Ischemia
af: Xinwu Huang, et al.
Udgivet: (2017-06-01)

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Characteristics and Usefulness of the Direct Renin Inhibitor Aliskiren
af: Atsuhiro Ichihara, et al.
Udgivet: (2010-01-01)

Renin-Angiotensin-Aldosterone System Inhibitors, Statins, and Beta-Blockers in Diabetic Patients With Critical Limb Ischemia and Foot Lesions
af: Paolo Cimaglia MD, et al.
Udgivet: (2022-05-01)

A systematic review of the role of renin angiotensin aldosterone system genes in diabetes mellitus, diabetic retinopathy and diabetic neuropathy
af: Zohreh Rahimi, et al.
Udgivet: (2014-01-01)

Renin-angiotensin-aldosterone system inhibitors – a realm of confusion in COVID-19
af: Angela Madalina Lazar
Udgivet: (2021-07-01)

Impact of the withdrawal of renin-angiotensin-aldosterone inhibitors on mortality in COVID-19 patients
af: Juan Caro-Codón, et al.
Udgivet: (2022-10-01)

Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea.
af: Jungchan Park, et al.
Udgivet: (2021-01-01)

Efficacy of astragalus combined with renin-angiotensin-aldosterone system blockers in the treatment of stage III diabetic nephropathy: a systematic review and meta-analysis
af: Yu-qiong Lin, et al.
Udgivet: (2024-12-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
af: M. L. Maksimov, et al.
Udgivet: (2010-04-01)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
af: Eliecer Coto, et al.
Udgivet: (2021-03-01)

The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
af: Maricica Pacurari, et al.
Udgivet: (2014-01-01)